10-Q 1 sxi20240930_10q.htm FORM 10-Q sxi20240930_10q.htm
0000310354 STANDEX INTERNATIONAL CORP/DE/ false --06-30 Q1 2025 1,931 1,882 1.50 1.50 60,000,000 60,000,000 27,984,278 27,984,278 11,812,917 11,761,700 16,171,361 16,222,578 0.2 0.5 0.30 0.2 0.3 0.28 5 http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent March 23, 2025 April 24, 2025 March 24, 2025 0 5 false false false false EMEA consists primarily of Europe, Middle East and S. Africa. The fair value of our contingent consideration arrangement is determined based on our evaluation as to the probability and amount of any deferred compensation that has been earned to date. 00003103542024-07-012024-09-30 xbrli:shares 00003103542024-10-28 iso4217:USD 00003103542024-09-30 00003103542024-06-30 iso4217:USDxbrli:shares 00003103542023-07-012023-09-30 0000310354us-gaap:CommonStockMember2024-06-30 0000310354us-gaap:AdditionalPaidInCapitalMember2024-06-30 0000310354us-gaap:RetainedEarningsMember2024-06-30 0000310354us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-30 0000310354us-gaap:TreasuryStockCommonMember2024-06-30 0000310354us-gaap:CommonStockMember2024-07-012024-09-30 0000310354us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-30 0000310354us-gaap:RetainedEarningsMember2024-07-012024-09-30 0000310354us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-30 0000310354us-gaap:TreasuryStockCommonMember2024-07-012024-09-30 0000310354us-gaap:CommonStockMember2024-09-30 0000310354us-gaap:AdditionalPaidInCapitalMember2024-09-30 0000310354us-gaap:RetainedEarningsMember2024-09-30 0000310354us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-30 0000310354us-gaap:TreasuryStockCommonMember2024-09-30 0000310354us-gaap:CommonStockMember2023-06-30 0000310354us-gaap:AdditionalPaidInCapitalMember2023-06-30 0000310354us-gaap:RetainedEarningsMember2023-06-30 0000310354us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-30 0000310354us-gaap:TreasuryStockCommonMember2023-06-30 00003103542023-06-30 0000310354us-gaap:CommonStockMember2023-07-012023-09-30 0000310354us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-30 0000310354us-gaap:RetainedEarningsMember2023-07-012023-09-30 0000310354us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-30 0000310354us-gaap:TreasuryStockCommonMember2023-07-012023-09-30 0000310354us-gaap:CommonStockMember2023-09-30 0000310354us-gaap:AdditionalPaidInCapitalMember2023-09-30 0000310354us-gaap:RetainedEarningsMember2023-09-30 0000310354us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-30 0000310354us-gaap:TreasuryStockCommonMember2023-09-30 00003103542023-09-30 0000310354us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-07-012024-09-30 0000310354us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012023-09-30 0000310354sxi:AmranInstrumentTransformersAndNarayanPowertechPvtLtdMemberus-gaap:SubsequentEventMember2024-10-292024-10-29 xbrli:pure 0000310354sxi:AmranInstrumentTransformersMemberus-gaap:SubsequentEventMember2024-10-292024-10-29 0000310354sxi:NarayanPowertechPvtLtdMemberus-gaap:SubsequentEventMember2024-10-292024-10-29 0000310354sxi:SanyuSwitchCoLtdMember2024-02-192024-02-19 0000310354sxi:SanyuSwitchCoLtdMember2024-01-012024-03-31 0000310354sxi:SanyuSwitchCoLtdMember2024-02-19 0000310354sxi:SanyuSwitchCoLtdMemberus-gaap:TradeNamesMember2023-07-31 0000310354sxi:SanyuSwitchCoLtdMemberus-gaap:CustomerRelationshipsMember2024-02-19 utr:Y 0000310354sxi:SanyuSwitchCoLtdMember2024-04-012024-04-01 0000310354sxi:SanyuSwitchCoLtdMember2024-09-302024-09-30 0000310354sxi:SanyuSwitchCoLtdMember2024-04-01 0000310354sxi:SanyuSwitchCoLtdMember2024-09-30 0000310354sxi:SanyuSwitchCoLtdMember2024-07-012024-09-30 0000310354sxi:MinntronixsMember2023-07-012023-07-01 0000310354sxi:MinntronixsMember2023-12-31 0000310354sxi:MinntronixsMemberus-gaap:TrademarksMember2023-12-31 0000310354sxi:MinntronixsMemberus-gaap:CustomerRelatedIntangibleAssetsMember2024-09-30 0000310354sxi:MinntronixsMember2024-09-30 0000310354sxi:MinntronixsMember2024-09-302024-09-30 0000310354sxi:SanyuElectricPteLtdMember2024-05-032024-05-03 0000310354sxi:SanyuElectricPteLtdMember2024-04-012024-06-30 0000310354sxi:SanyuElectricPteLtdMember2024-05-03 0000310354sxi:ElectronicsProductsGroupMember2024-07-012024-09-30 0000310354sxi:ElectronicsProductsGroupMember2023-07-012023-09-30 0000310354sxi:EngravingServicesMembersxi:EngravingGroupMember2024-07-012024-09-30 0000310354sxi:EngravingServicesMembersxi:EngravingGroupMember2023-07-012023-09-30 0000310354sxi:EngravingProductsMembersxi:EngravingGroupMember2024-07-012024-09-30 0000310354sxi:EngravingProductsMembersxi:EngravingGroupMember2023-07-012023-09-30 0000310354sxi:EngravingGroupMember2024-07-012024-09-30 0000310354sxi:EngravingGroupMember2023-07-012023-09-30 0000310354sxi:ScientificProductsAndServicesMembersxi:ScientificGroupMember2024-07-012024-09-30 0000310354sxi:ScientificProductsAndServicesMembersxi:ScientificGroupMember2023-07-012023-09-30 0000310354sxi:EngineeringTechnologiesComponentsMembersxi:EngineeringTechnologiesGroupMember2024-07-012024-09-30 0000310354sxi:EngineeringTechnologiesComponentsMembersxi:EngineeringTechnologiesGroupMember2023-07-012023-09-30 0000310354sxi:HydraulicsCylindersAndSystemMembersxi:SpecialtySolutionsGroupMember2024-07-012024-09-30 0000310354sxi:HydraulicsCylindersAndSystemMembersxi:SpecialtySolutionsGroupMember2023-07-012023-09-30 0000310354sxi:MerchandisingDisplayMembersxi:SpecialtySolutionsGroupMember2024-07-012024-09-30 0000310354sxi:MerchandisingDisplayMembersxi:SpecialtySolutionsGroupMember2023-07-012023-09-30 0000310354sxi:SpecialtySolutionsGroupMember2024-07-012024-09-30 0000310354sxi:SpecialtySolutionsGroupMember2023-07-012023-09-30 0000310354country:US2024-07-012024-09-30 0000310354country:US2023-07-012023-09-30 0000310354srt:AsiaPacificMember2024-07-012024-09-30 0000310354srt:AsiaPacificMember2023-07-012023-09-30 0000310354us-gaap:EMEAMember2024-07-012024-09-30 0000310354us-gaap:EMEAMember2023-07-012023-09-30 0000310354sxi:OtherAmericasMember2024-07-012024-09-30 0000310354sxi:OtherAmericasMember2023-07-012023-09-30 0000310354us-gaap:TransferredAtPointInTimeMember2024-07-012024-09-30 0000310354us-gaap:TransferredAtPointInTimeMember2023-07-012023-09-30 0000310354us-gaap:TransferredOverTimeMember2024-07-012024-09-30 0000310354us-gaap:TransferredOverTimeMember2023-07-012023-09-30 0000310354sxi:DeferredCompensationPlanMember2024-09-30 0000310354sxi:DeferredCompensationPlanMemberus-gaap:FairValueInputsLevel1Member2024-09-30 0000310354sxi:DeferredCompensationPlanMemberus-gaap:FairValueInputsLevel2Member2024-09-30 0000310354sxi:DeferredCompensationPlanMemberus-gaap:FairValueInputsLevel3Member2024-09-30 0000310354us-gaap:FairValueInputsLevel1Member2024-09-30 0000310354us-gaap:FairValueInputsLevel2Member2024-09-30 0000310354us-gaap:FairValueInputsLevel3Member2024-09-30 0000310354sxi:DeferredCompensationPlanMember2024-06-30 0000310354sxi:DeferredCompensationPlanMemberus-gaap:FairValueInputsLevel1Member2024-06-30 0000310354sxi:DeferredCompensationPlanMemberus-gaap:FairValueInputsLevel2Member2024-06-30 0000310354sxi:DeferredCompensationPlanMemberus-gaap:FairValueInputsLevel3Member2024-06-30 0000310354us-gaap:FairValueInputsLevel1Member2024-06-30 0000310354us-gaap:FairValueInputsLevel2Member2024-06-30 0000310354us-gaap:FairValueInputsLevel3Member2024-06-30 0000310354sxi:SanyuElectricPteLtdMember2024-09-30 0000310354sxi:ElectronicsProductsGroupMember2024-06-30 0000310354sxi:ElectronicsProductsGroupMember2024-09-30 0000310354sxi:EngravingGroupMember2024-06-30 0000310354sxi:EngravingGroupMember2024-09-30 0000310354sxi:ScientificGroupMember2024-06-30 0000310354sxi:ScientificGroupMember2024-07-012024-09-30 0000310354sxi:ScientificGroupMember2024-09-30 0000310354sxi:EngineeringTechnologiesGroupMember2024-06-30 0000310354sxi:EngineeringTechnologiesGroupMember2024-07-012024-09-30 0000310354sxi:EngineeringTechnologiesGroupMember2024-09-30 0000310354sxi:SpecialtySolutionsGroupMember2024-06-30 0000310354sxi:SpecialtySolutionsGroupMember2024-09-30 00003103542023-07-012024-06-30 0000310354us-gaap:LineOfCreditMember2024-09-30 0000310354us-gaap:LineOfCreditMember2024-06-30 0000310354sxi:AmendedAndRestatedCreditAgreementMember2019-10-012019-12-31 0000310354sxi:AmendedAndRestatedCreditAgreementMember2019-12-31 0000310354sxi:SwingLineLoanMember2019-12-31 0000310354us-gaap:LetterOfCreditMember2019-12-31 0000310354us-gaap:StandbyLettersOfCreditMember2024-09-30 thunderdome:item 0000310354us-gaap:InterestRateSwapMember2024-06-30 0000310354sxi:InterestRateSwapEffectiveFebruary62023Member2024-09-30 0000310354sxi:InterestRateSwapEffectiveFebruary62023Member2024-07-012024-09-30 0000310354sxi:InterestRateSwapEffectiveFebruary62023Member2024-06-30 0000310354sxi:InterestRateSwapEffectiveApril242020Member2024-09-30 0000310354sxi:InterestRateSwapEffectiveApril242020Member2024-07-012024-09-30 0000310354sxi:InterestRateSwapEffectiveApril242020Member2024-06-30 0000310354sxi:InterestRateSwapsEffectiveFebruary232023Member2024-09-30 0000310354sxi:InterestRateSwapsEffectiveFebruary232023Member2024-07-012024-09-30 0000310354sxi:InterestRateSwapsEffectiveFebruary232023Member2024-06-30 0000310354sxi:InterestRateSwapsEffectiveMay252023Member2024-09-30 0000310354sxi:InterestRateSwapsEffectiveMay252023Member2024-06-30 0000310354us-gaap:ForeignExchangeContractMember2024-09-30 0000310354us-gaap:ForeignExchangeContractMember2024-06-30 iso4217:CAD 0000310354us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-09-30 0000310354us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-30 0000310354us-gaap:AccruedLiabilitiesMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-09-30 0000310354us-gaap:AccruedLiabilitiesMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-30 0000310354us-gaap:InterestRateSwapMember2024-07-012024-09-30 0000310354us-gaap:InterestRateSwapMember2023-07-012023-09-30 0000310354us-gaap:ForeignExchangeContractMember2024-07-012024-09-30 0000310354us-gaap:ForeignExchangeContractMember2023-07-012023-09-30 0000310354us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2024-07-012024-09-30 0000310354us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2023-07-012023-09-30 0000310354us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2024-07-012024-09-30 0000310354us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2023-07-012023-09-30 0000310354country:US2024-07-012024-09-30 0000310354country:US2023-07-012023-09-30 0000310354us-gaap:ForeignPlanMember2024-07-012024-09-30 0000310354us-gaap:ForeignPlanMember2023-07-012023-09-30 0000310354country:US2024-09-30 0000310354country:US2024-06-30 0000310354us-gaap:FundedPlanMembercountry:US2024-07-012024-09-30 0000310354us-gaap:FundedPlanMembercountry:US2024-09-30 0000310354us-gaap:UnfundedPlanMembercountry:US2024-07-012024-09-30 0000310354us-gaap:UnfundedPlanMembercountry:US2024-09-30 0000310354us-gaap:UnfundedPlanMembercountry:DE2024-07-012024-09-30 0000310354us-gaap:UnfundedPlanMembercountry:DE2024-09-30 0000310354us-gaap:EmployeeStockOptionMember2024-07-012024-09-30 0000310354us-gaap:EmployeeStockOptionMember2023-07-012023-09-30 0000310354sxi:PerformanceStockUnitsMember2024-07-012024-09-30 0000310354sxi:PerformanceStockUnitsMember2023-07-012023-09-30 0000310354sxi:ScientificGroupMember2023-07-012023-09-30 0000310354sxi:EngineeringTechnologiesGroupMember2023-07-012023-09-30 0000310354us-gaap:CorporateAndOtherMember2024-07-012024-09-30 0000310354us-gaap:CorporateAndOtherMember2023-07-012023-09-30 0000310354sxi:InvoluntaryEmployeeSeveranceAndBenefitCostsMembersxi:CurrentYearRestructuringInitiativesMember2024-07-012024-09-30 0000310354us-gaap:OtherRestructuringMembersxi:CurrentYearRestructuringInitiativesMember2024-07-012024-09-30 0000310354sxi:CurrentYearRestructuringInitiativesMember2024-07-012024-09-30 0000310354sxi:InvoluntaryEmployeeSeveranceAndBenefitCostsMembersxi:PriorYearInitiativesMember2024-07-012024-09-30 0000310354us-gaap:OtherRestructuringMembersxi:PriorYearInitiativesMember2024-07-012024-09-30 0000310354sxi:PriorYearInitiativesMember2024-07-012024-09-30 0000310354sxi:InvoluntaryEmployeeSeveranceAndBenefitCostsMembersxi:CurrentYearRestructuringInitiativesMember2023-07-012023-09-30 0000310354us-gaap:OtherRestructuringMembersxi:CurrentYearRestructuringInitiativesMember2023-07-012023-09-30 0000310354sxi:CurrentYearRestructuringInitiativesMember2023-07-012023-09-30 0000310354sxi:InvoluntaryEmployeeSeveranceAndBenefitCostsMembersxi:PriorYearInitiativesMember2023-07-012023-09-30 0000310354us-gaap:OtherRestructuringMembersxi:PriorYearInitiativesMember2023-07-012023-09-30 0000310354sxi:PriorYearInitiativesMember2023-07-012023-09-30 0000310354sxi:InvoluntaryEmployeeSeveranceAndBenefitCostsMember2023-07-012023-09-30 0000310354us-gaap:OtherRestructuringMember2023-07-012023-09-30 0000310354sxi:InvoluntaryEmployeeSeveranceAndBenefitCostsMembersxi:CurrentYearRestructuringInitiativesMember2024-06-30 0000310354us-gaap:OtherRestructuringMembersxi:CurrentYearRestructuringInitiativesMember2024-06-30 0000310354sxi:CurrentYearRestructuringInitiativesMember2024-06-30 0000310354sxi:InvoluntaryEmployeeSeveranceAndBenefitCostsMembersxi:CurrentYearRestructuringInitiativesMember2024-09-30 0000310354us-gaap:OtherRestructuringMembersxi:CurrentYearRestructuringInitiativesMember2024-09-30 0000310354sxi:CurrentYearRestructuringInitiativesMember2024-09-30 0000310354sxi:InvoluntaryEmployeeSeveranceAndBenefitCostsMembersxi:PriorYearInitiativesMember2024-06-30 0000310354us-gaap:OtherRestructuringMembersxi:PriorYearInitiativesMember2024-06-30 0000310354sxi:PriorYearInitiativesMember2024-06-30 0000310354sxi:InvoluntaryEmployeeSeveranceAndBenefitCostsMembersxi:PriorYearInitiativesMember2024-09-30 0000310354us-gaap:OtherRestructuringMembersxi:PriorYearInitiativesMember2024-09-30 0000310354sxi:PriorYearInitiativesMember2024-09-30 0000310354sxi:InvoluntaryEmployeeSeveranceAndBenefitCostsMembersxi:PriorYearInitiativesMember2023-06-30 0000310354us-gaap:OtherRestructuringMembersxi:PriorYearInitiativesMember2023-06-30 0000310354sxi:PriorYearInitiativesMember2023-06-30 0000310354sxi:InvoluntaryEmployeeSeveranceAndBenefitCostsMembersxi:PriorYearInitiativesMember2023-09-30 0000310354us-gaap:OtherRestructuringMembersxi:PriorYearInitiativesMember2023-09-30 0000310354sxi:PriorYearInitiativesMember2023-09-30 0000310354sxi:InvoluntaryEmployeeSeveranceAndBenefitCostsMembersxi:EngravingGroupMember2024-07-012024-09-30 0000310354us-gaap:OtherRestructuringMembersxi:EngravingGroupMember2024-07-012024-09-30 0000310354sxi:InvoluntaryEmployeeSeveranceAndBenefitCostsMemberus-gaap:CorporateMember2024-07-012024-09-30 0000310354us-gaap:OtherRestructuringMemberus-gaap:CorporateMember2024-07-012024-09-30 0000310354us-gaap:CorporateMember2024-07-012024-09-30 0000310354sxi:InvoluntaryEmployeeSeveranceAndBenefitCostsMember2024-07-012024-09-30 0000310354us-gaap:OtherRestructuringMember2024-07-012024-09-30 0000310354sxi:InvoluntaryEmployeeSeveranceAndBenefitCostsMembersxi:ElectronicsProductsGroupMember2023-07-012023-09-30 0000310354us-gaap:OtherRestructuringMembersxi:ElectronicsProductsGroupMember2023-07-012023-09-30 0000310354sxi:InvoluntaryEmployeeSeveranceAndBenefitCostsMembersxi:EngravingGroupMember2023-07-012023-09-30 0000310354us-gaap:OtherRestructuringMembersxi:EngravingGroupMember2023-07-012023-09-30 0000310354sxi:InvoluntaryEmployeeSeveranceAndBenefitCostsMembersxi:EngineeringTechnologiesGroupMember2023-07-012023-09-30 0000310354us-gaap:OtherRestructuringMembersxi:EngineeringTechnologiesGroupMember2023-07-012023-09-30 0000310354sxi:InvoluntaryEmployeeSeveranceAndBenefitCostsMemberus-gaap:CorporateMember2023-07-012023-09-30 0000310354us-gaap:OtherRestructuringMemberus-gaap:CorporateMember2023-07-012023-09-30 0000310354us-gaap:CorporateMember2023-07-012023-09-30 0000310354srt:ScenarioForecastMember2024-10-012025-06-30 0000310354sxi:SpecialtySolutionsGroupMembersxi:ProconPumpsBusinessMember2023-02-282023-02-28 0000310354us-gaap:DiscontinuedOperationsDisposedOfBySaleMembersxi:ProconPumpsBusinessMember2022-07-012023-06-30 0000310354sxi:SpecialtySolutionsGroupMember2022-07-012023-06-30 0000310354sxi:MinntronixsMember2024-07-012024-09-30 0000310354us-gaap:PensionPlansDefinedBenefitMember2024-07-012024-09-30 0000310354us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2024-07-012024-09-30
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 

     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2024

 

    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number 001-07233

 

STANDEX INTERNATIONAL CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware

 

31-0596149

(State of incorporation)

(IRS Employer Identification No.)

 

23 Keewaydin drive, Salem, New Hampshire

03079

(Address of principal executive offices)

(Zip Code)

 

(603) 893-9701

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, Par Value $1.50 Per Share

SXI

New York Stock Exchange

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☒

 

 

Accelerated filer ☐

 

Non-accelerated filer ☐  

Smaller reporting company 

 

   

Emerging growth company 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes     No ☒

 

The number of shares of Registrant's Common Stock outstanding on October 28, 2024 was 12,081,695

  

1

   

 

STANDEX INTERNATIONAL CORPORATION

 

 

INDEX

 

 

 

 

Page No.

PART I.  FINANCIAL INFORMATION:

 

 

 

 

Item 1.

 

 

 

 

 

 

Condensed Consolidated Balance Sheets as of September 30, 2024 and June 30, 2024 (unaudited)

3

 

 

 

 

Condensed Consolidated Statements of Operations for the three months ended September 30, 2024 and 2023 (unaudited)

4

 

 

 

 

Condensed Consolidated Statements of Comprehensive Income (Loss) for the three months ended September 30, 2024 and 2023 (unaudited)

5

 

 

 

 

Condensed Consolidated Statements of Stockholders’ Equity for the three months ended September 30, 2024 and 2023 (unaudited)

6

 

 

 

 

Condensed Consolidated Statements of Cash Flows for the three months ended September 30, 2024 and 2023 (unaudited)

7

 

 

 

 

Notes to Unaudited Condensed Consolidated Financial Statements

8

 

 

 

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

26

 

 

 

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

37

 

 

 

Item 4.

Controls and Procedures

38

 

 

 

PART II.  OTHER INFORMATION:

 

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

39

     

Item 5.

Other Information

39
     

Item 6.

Exhibits

40

 

2

 
 

 

PART I. FINANCIAL INFORMATION

ITEM 1

STANDEX INTERNATIONAL CORPORATION AND SUBSIDIARIES

Unaudited Condensed Consolidated Balance Sheets

 

  September 30,  June 30, 

(In thousands, except per share data)

 

2024

  

2024

 

ASSETS

        

Current assets:

        

Cash and cash equivalents

 $164,584  $154,203 

Accounts receivable, less allowance for credit losses of $1,931 and $1,882 at September 30, 2024 and June 30, 2024, respectively

  118,697   121,365 

Inventories

  90,121   87,106 

Contract assets

  50,087   45,393 

Prepaid expenses and other current assets

  23,658   22,028 

Total current assets

  447,147   430,095 
         

Property, plant, and equipment, net

  138,373   134,963 

Intangible assets, net

  78,957   78,673 

Goodwill

  292,180   281,283 

Deferred tax asset

  19,303   17,450 

Operating lease right-of-use asset

  36,128   37,078 

Other non-current assets

  25,794   25,515 

Total non-current assets

  590,735   574,962 
         

Total assets

 $1,037,882  $1,005,057 
         

LIABILITIES AND STOCKHOLDERS' EQUITY

        

Current liabilities:

        

Accounts payable

 $66,505  $63,364 

Accrued liabilities

  52,885   56,698 

Income taxes payable

  6,607   7,503 

Total current liabilities

  125,997   127,565 
         

Long-term debt

  148,985   148,876 

Operating lease long-term liabilities

  29,722   30,725 

Accrued pension and other non-current liabilities

  75,157   76,388 

Total non-current liabilities

  253,864   255,989 
         

Contingencies (Note 15)

          
         

Stockholders' equity:

        

Common stock, par value $1.50 per share, 60,000,000 shares authorized, 27,984,278 shares issued, 11,812,917 and 11,761,700 shares outstanding at September 30, 2024 and June 30, 2024

  41,976   41,976 

Additional paid-in capital

  108,383   106,193 

Retained earnings

  1,100,924   1,086,277 

Accumulated other comprehensive loss

  (160,939)  (182,956)

Treasury shares: 16,171,361 and 16,222,578 shares at September 30, 2024 and June 30, 2024

  (432,323)  (429,987)

Total stockholders' equity

  658,021   621,503 
         

Total liabilities and stockholders' equity

 $1,037,882  $1,005,057 

 

See notes to unaudited condensed consolidated financial statements

 

3

 
 

 

STANDEX INTERNATIONAL CORPORATION AND SUBSIDIARIES

Unaudited Condensed Consolidated Statements of Operations

 

   

Three Months Ended

 
   

September 30,

 

(In thousands, except per share data)

 

2024

   

2023

 

Net sales

  $ 170,464     $ 184,774  

Cost of sales

    100,391       112,139  

Gross profit

    70,073       72,635  

Selling, general, and administrative expenses

    43,048       43,585  

(Gain) loss on sale of business

    -       (274 )

Restructuring costs

    1,086       1,906  

Acquisition related costs

    1,840       501  

Total operating expenses

    45,974       45,718  

Income from operations

    24,099       26,917  

Interest expense

    977       1,276  

Other non-operating (income) expense, net

    (28 )     846  

Income from continuing operations before income taxes

    23,150       24,795  

Provision for income taxes

    4,962       5,903  

Income from continuing operations

    18,188       18,892  

Income (loss) from discontinued operations, net of tax

    9       (78 )

Net income

  $ 18,197     $ 18,814  
                 

Basic earnings (loss) per share:

               

Continuing operations

  $ 1.54     $ 1.61  

Discontinued operations

    -       (0.01 )

Total

  $ 1.54     $ 1.60  

Diluted earnings (loss) per share:

               

Continuing operations

  $ 1.53     $ 1.58  

Discontinued operations

    -       -  

Total

  $ 1.53     $ 1.58  
                 

Weighted average number of shares:

               

Basic

    11,787       11,742  

Diluted

    11,904       11,933  

 

See notes to unaudited condensed consolidated financial statements

 

4

 
 

STANDEX INTERNATIONAL CORPORATION AND SUBSIDIARIES

Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss)

 

   

Three Months Ended

 
   

September 30,

 

(In thousands)

 

2024

   

2023

 

Net income

  $ 18,197     $ 18,814  

Other comprehensive income (loss):

               

Defined benefit pension plans:

               

Actuarial gains (losses) and other changes in unrecognized costs, net of tax

  $ (218 )   $ 121  

Amortization of unrecognized costs, net of tax

    799       596  

Derivative instruments:

               

Change in unrealized gains (losses), net of tax

    (290 )     783  

Amortization of unrealized gains (losses) into interest expense, net of tax

    (1,284 )     (1,501 )

Foreign currency translation gains (losses), net of tax

    23,010       (9,098 )

Other comprehensive income (loss), net of tax

  $ 22,017     $ (9,099 )

Comprehensive income

  $ 40,214     $ 9,715  

 

See notes to unaudited condensed consolidated financial statements

 

5

 
 

STANDEX INTERNATIONAL CORPORATION AND SUBSIDIARIES 

Unaudited Condensed Consolidated Statements of Stockholders' Equity 

 

              

Accumulated Other

             

For the three month period ended

    Additional     Comprehensive     Total 

September 30, 2024

 

Common

  

Paid-in

  

Retained

  

Income

  

Treasury Stock

  

Stockholders’

 

(in thousands, except as specified)

 

Stock

  

Capital

  

Earnings

  

(Loss)

  

Shares

  

Amount

  

Equity

 

Balance, June 30, 2024

 $41,976  $106,193  $1,086,277  $(182,956)  16,222  $(429,987) $621,503 

Stock issued under incentive compensation plans and employee purchase plans

  -   (378)  -   -   (76)  2,015   1,637 

Stock-based compensation

  -   2,568   -   -   -   -   2,568 

Treasury stock acquired

  -         -   25   (4,351)  (4,351)

Comprehensive income:

      -   -                 

Net income

  -   -   18,197   -   -   -   18,197 

Foreign currency translation adjustment

  -   -   -   23,010   -   -   23,010 

Pension, net of tax of $0.2 million

  -   -   -   581   -   -   581 

Change in fair value of derivatives, net of tax of $0.5 million

  -   -   -   (1,574)  -   -   (1,574)

Dividends declared ($0.30 per share)

  -   -   (3,550)  -   -   -   (3,550)

Balance, September 30, 2024

 $41,976  $108,383  $1,100,924  $(160,939)  16,171  $(432,323) $658,021 
                             

For the three month period ended September 30, 2023

                            

(in thousands, except as specified)

                            

Balance, June 30, 2023

 $41,976  $100,555  $1,027,279  $(158,477)  16,239  $(403,884) $607,449 

Stock issued under incentive compensation plans and employee purchase plans

  -   (4,035)  -   -   (189)  4,804   769 

Stock-based compensation

  -   2,193   -   -   -   -   2,193 

Treasury stock acquired

  -   -   -   -   139   (22,089)  (22,089)

Comprehensive income:

                            

Net income

  -   -   18,814   -   -   -   18,814 

Foreign currency translation adjustment

  -   -      (9,098)  -   -   (9,098)

Pension, net of tax of $0.2 million

  -   -   -   717   -   -   717 

Change in fair value of derivatives, net of tax of $0.3 million

  -   -   -   (718)  -   -   (718)

Dividends declared ($0.28 per share)

  -   -   (3,398)  -   -   -   (3,398)

Balance, September 30, 2023

 $41,976  $98,713  $1,042,695  $(167,576)  16,189  $(421,169) $594,639 

 

See notes to unaudited condensed consolidated financial statements

 

6

 
 

STANDEX INTERNATIONAL CORPORATION AND SUBSIDIARIES

 Unaudited Condensed Consolidated Statements of Cash Flows

 

   

Three Months Ended

 
   

September 30,

 

(In thousands)

 

2024

   

2023

 

Cash flows from operating activities

               

Net income

  $ 18,197     $ 18,814  

Income (loss) from discontinued operations

    9       (78 )

Income from continuing operations

    18,188       18,892  

Adjustments to reconcile net income to net cash provided by (used in) operating activities:

               

Depreciation and amortization

    7,061       7,082  

Stock-based compensation

    2,568       2,193  

Non-cash portion of restructuring charge

    (143 )     397  

(Gain) loss on sale of business

    -       (274 )

Contributions to defined benefit plans

    (3,379 )     (49 )

Changes in operating assets and liabilities, net

    (6,748 )     (11,834 )

Net cash provided by (used in) operating activities - continuing operations

    17,547       16,407  

Net cash provided by (used in) operating activities - discontinued operations

    26       (227 )

Net cash provided by (used in) operating activities

    17,573       16,180  

Cash flows from investing activities

               

Expenditures for property, plant, and equipment

    (6,725 )     (4,338 )

Proceeds from sale of business

    -       274  

Expenditures for acquisitions, net of cash acquired

    -       (29,229 )

Other investing activity

    411       -  

Net cash provided by (used in) investing activities

    (6,314 )     (33,293 )

Cash flows from financing activities

               

Payments of debt

    -       (25,000 )

Activity under share-based payment plans

    1,637       768  

Purchases of treasury stock

    (4,382 )     (22,158 )

Cash dividends paid

    (3,528 )     (3,288 )

Net cash provided by (used in) financing activities

    (6,273 )     (49,678 )

Effect of exchange rate changes on cash and cash equivalents

    5,395       (2,085 )

Net change in cash and cash equivalents

    10,381       (68,876 )

Cash and cash equivalents at beginning of year

    154,203       195,706  

Cash and cash equivalents at end of period

  $ 164,584     $ 126,830  
                 

Supplemental Disclosure of Cash Flow Information:

               

Cash paid during the year for:

               

Interest

  $ 895     $ 1,280  

Income taxes, net of refunds

  $ 5,479     $ 5,119  

 

See notes to unaudited condensed consolidated financial statements

 

7

 

 

STANDEX INTERNATIONAL CORPORATION

Notes to Unaudited Condensed Consolidated Financial Statements

 

 

1)     Management Statement

 

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the results of operations for the three months ended September 30, 2024 and 2023, the cash flows for the three months ended September 30, 2024 and 2023 and the financial position of Standex International Corporation (“Standex”, the “Company”, “we”, “us”, or “our”), at September 30, 2024. The interim results are not necessarily indicative of results for a full year. The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. The unaudited condensed consolidated financial statements and notes do not contain information which would substantially duplicate the disclosures contained in the audited annual consolidated financial statements and notes for the year ended June 30, 2024. The condensed consolidated balance sheet at June 30, 2024 was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. The financial statements contained herein should be read in conjunction with the Annual Report on Form 10-K and in particular the audited consolidated financial statements for the year ended June 30, 2024. Unless otherwise noted, references to years are to the Company’s fiscal years. Currently the fiscal year end is June 30.  For further clarity, the Company's fiscal year 2025 includes the twelve-month period from July 1, 2024 to June 30, 2025.

 

The preparation of consolidated financial statements in conformity with GAAP requires the use of estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities at the date of the financial statements and for the period then ended. Estimates are based on historical experience, actuarial estimates, current conditions and various other assumptions that are believed to be reasonable under the circumstances. These estimates form the basis for making judgments about the carrying values of assets and liabilities when they are not readily apparent from other sources. These estimates assist in the identification and assessment of the accounting treatment necessary with respect to commitments and contingencies. Actual results  may differ from these estimates under different assumptions or conditions. The estimates and assumptions used in the preparation of the consolidated financial statements have considered the implications on the Company as a result of ongoing global events and related economic impacts. As a result, there is heightened volatility and uncertainty around supply chain performance, labor availability, and customer demand. However, the magnitude of such impact on the Company’s business and its duration is uncertain. The Company is not aware of any specific event or circumstance that would require an update to its estimates or adjustments to the carrying value of its assets and liabilities as of  September 30, 2024 and the issuance date of the quarterly report on Form 10-Q.

 

The Company considers events or transactions that occur after the balance sheet date but before the financial statements are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. The Company evaluated subsequent events through the date and time its unaudited condensed consolidated financial statements were issued. 

 

Research and development expenditures are expensed as incurred. Total research and development costs, which are classified under selling, general, and administrative expenses, were $4.8 million and $5.3 million for the three months ended September 30, 2024 and 2023, respectively.

 

Recently Issued Accounting Pronouncements

 

From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective date. Unless otherwise discussed below, the Company does not believe that the adoption of recently issued standards had or  may have a material impact on its unaudited condensed consolidated financial statements or disclosures.

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280) ("ASU 2023-07"). This update provides, among other things, enhanced segment disclosure requirements including disclosures about significant segment expenses. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company will review the extent of new disclosures necessary in the coming quarters, prior to implementation during fiscal year 2025. Other than additional disclosure, the Company does not expect a change to its condensed consolidated financial statements upon adoption.

 

8

 
In December 2023, the FASB issued ASU 2023- 09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures. This ASU is expected to enhance the transparency and decision usefulness of income tax disclosures by requiring public business entities on an annual basis to disclose specific categories in the rate reconciliation, additional information for reconciling items that meet a quantitative threshold, and certain information about income taxes paid. This ASU is effective for fiscal years beginning after December 15, 2024. The amendments in this ASU are required to be applied on a prospective basis and retrospective adoption is permitted. The Company is currently evaluating the effect of adopting this new accounting guidance, which would be applicable to fiscal year 2026.

 

 

2)     Acquisitions

 

At the time of the acquisition and as of  September 30, 2024, the Company evaluated the significance of each acquisition on a standalone basis and in aggregate, considering both qualitative and quantitative factors.


On October 29, 2024 the Company announced the acquisition, in separate transactions, of privately-held US-based Amran Instrument Transformers and India-based Narayan Powertech Pvt. Ltd. (going forward referred to as "Amran/Narayan Group") in cash and stock transactions. These transactions represent a combined enterprise value of approximately $462 million, comprised of 85% cash and 15% in Standex common stock for Amran Instrument Transformers and 90% cash and 10% in Standex common stock for Narayan Powertech Pvt. Ltd. The 10% share exchange related to Narayan Powertech Pvt. Ltd. is subject to India regulatory approval, which is expected to take up to six months. The cash consideration of the transactions was financed using cash-on-hand, existing credit facilities, and a $250 million 364-day term loan with existing lenders.  Its results will be reported in the Electronics segment beginning in the second quarter of fiscal year 2025.
 

Sanyu

 

On February 19, 2024, the Company completed the purchase of all the issued and outstanding equity interests of Sanyu Switch Co., Ltd ("Sanyu"), a privately held company for $20.9 million, net of cash acquired. Sanyu designs and manufactures reed relays for test and measurement and other switching applications.  Products include surface mount relays, high current relays, high insulation relays, high density relays for test boards, and RF relays which are used in semi-conductors, other electronics manufacturing and other switching applications. Sanyu's results are reported within the Company's Electronics segment. The Company paid $22.2 million in cash in the third quarter of fiscal year 2024 and recorded $2.5 million as holdback amounts.  Holdback amounts are used to withhold a portion of the initial purchase price payment until certain post-closing conditions are satisfied and are expected to be settled within 24 months from the date of acquisition.

 

The purchase price was allocated to the net tangible and identifiable intangible assets acquired and liabilities assumed based on a valuation of their fair values on the closing date. Goodwill recorded from this transaction is attributable to Sanyu's technical and applications expertise, which is highly complementary to the Company's existing business.

 

Identifiable intangible assets of $2.6 million consist primarily of $0.7 million for indefinite lived tradenames and $1.9 million of customer relationships to be amortized over 12 years. The goodwill of $9.2 million created by the transaction is not deductible for income tax purposes. The accounting for business combinations requires estimates and judgments regarding expectations for future cash flows of the acquired business, and the allocations of those cash flows to identifiable tangible and intangible assets, in determining the assets acquired and liabilities assumed. The fair values assigned to tangible and intangible assets acquired and liabilities assumed are based on management's best estimates and assumptions, as well as other information compiled by management, including valuations that utilize customary valuation procedures and techniques. 

 

The components of the fair value of the Sanyu acquisition, including the preliminary allocation of the purchase price are as follows (in thousands): 

 

  

Preliminary Allocation as of March 31, 2024

  

Adjustments

  

Preliminary Allocation as of September 30, 2024

 

Total purchase consideration:

            

Cash payments

 $22,178  $-  $22,178 

Holdbacks

  2,464   -   2,464 

Less cash acquired

  (3,711)  -   (3,711)

Total

 $20,931  $-  $20,931 
             
             

Identifiable assets acquired and liabilities assumed:

            

Other acquired assets

 $9,453  $(1,462) $7,991 

Inventories

  5,709   (5)  5,704 

Property, plant, and equipment

  4,791   (254)  4,537 

Identifiable intangible assets

  2,600   -   2,600 

Goodwill

  6,696   2,494   9,190 

Liabilities assumed

  (8,318)  (773)  (9,091)

Total

 $20,931  $-  $20,931 

 

 

9

 

Minntronix

 

On July 31, 2023, the Company paid $29.2 million in cash for the purchase of all the issued and outstanding equity interests of Minntronix, a privately held company. Minntronix designs and manufactures customized as well as standard magnetics components and products including transformers, inductors, current sensors, coils, chokes, and filters. The products are used in applications across cable fiber, smart meters, industrial control and lighting, electric vehicles, and home security markets. Minntronix' results are reported within the Company's Electronics segment.

 

The purchase price was allocated to the net tangible and identifiable intangible assets acquired and liabilities assumed based on a valuation of their fair values on the closing date. Goodwill recorded from this transaction is attributable to Minntronix's technical and applications expertise, which is highly complementary to the Company's existing business.

 

Identifiable intangible assets of $10.7 million consist primarily of $3.2 million for indefinite lived tradenames and $7.5 million of customer relationships to be amortized over 15 years. The goodwill of $13.9 million created by the transaction is not deductible for income tax purposes. The accounting for business combinations requires estimates and judgments regarding expectations for future cash flows of the acquired business, and the allocations of those cash flows to identifiable tangible and intangible assets, in determining the assets acquired and liabilities assumed. The fair values assigned to tangible and intangible assets acquired and liabilities assumed are based on management's best estimates and assumptions, as well as other information compiled by management, including valuations that utilize customary valuation procedures and techniques. 

 

The components of the fair value of the Minntronix acquisition, including the final allocation of the purchase price are as follows (in thousands): 

 

  

Final Allocation as of September 30, 2024

 

Fair value of business combination:

    

Cash payments

 $33,890 

Less, cash acquired

  (4,661)

Total

 $29,229 
     
     

Identifiable assets acquired and liabilities assumed:

    

Other acquired assets

 $8,282 

Customer backlog

  1,120 

Inventories

  1,780 

Property, plant, & equipment

  1,039 

Identifiable intangible assets

  10,700 

Goodwill

  13,889 

Liabilities assumed

  (7,581)

Total

 $29,229 

 

10

 

SEPL

 

On  May 3, 2024, the Company purchased all of the issued and outstanding equity interests of Sanyu Electric Pte Ltd, or SEPL, a privately held company for $3.5 million. Its results are reported within the Company's Electronics segment. The Company paid $1.1 million, net of cash acquired, in the fourth quarter of fiscal year 2024.  The goodwill of $1.9 million created by the transaction is not deductible for income tax purposes.

 

Acquisition Related Costs

 

Acquisition related costs include costs related to acquired businesses and other pending acquisitions. These costs consist of (i) deferred compensation arrangements and (ii) acquisition related professional service fees and expenses, including financial advisory, legal, accounting, and other outside services incurred in connection with acquisition activities, and regulatory matters related to acquired entities. These costs do not include purchase accounting expenses, which we define as acquired backlog and the step-up of inventory to fair value, or the amortization of the acquired intangible assets.

 

Acquisition related costs for the three months ended September 30, 2024 and 2023 were $1.8 million and $0.5 million, respectively.

 

 

3)     Revenue From Contracts With Customers

 

Most of the Company’s contracts have a single performance obligation which represents the product or service being sold to the customer. Some contracts include multiple performance obligations such as a product and the related installation and/or extended warranty. Additionally, most of the Company’s contracts offer assurance type warranties in connection with the sale of a product to customers. Assurance type warranties provide a customer with assurance that the product complies with agreed-upon specifications. Assurance type warranties do not represent a separate performance obligation.

 

In general, the Company recognizes revenue at the point in time control transfers to its customer based on predetermined shipping terms. Revenue is recognized over time under certain long-term contracts within the Engineering Technologies and Engraving segments for highly customized customer products that have no alternative use and in which the contract specifies the Company has a right to payment for its costs, plus a reasonable margin. For products manufactured over time, the transfer of control is measured pro rata, based upon current estimates of costs to complete such contracts. Losses on contracts are fully recognized in the period in which the losses become determinable. Revisions in profit estimates are reflected on a cumulative basis in the period in which the basis for such revision becomes known.

 

Disaggregation of Revenue from Contracts with Customers

 

The following table presents revenue from disaggregated by product line and segment (in thousands):

 

  

Three Months Ended

 

Revenue by Product Line

 

September 30, 2024

  

September 30, 2023

 
         

Electronics

 $77,733  $81,688 
         

Engraving Services

  29,821   38,736 

Engraving Products

  3,542   2,058 

Total Engraving

  33,363   40,794 
         

Scientific

  17,693   18,193 
         

Engineering Technologies

  20,530   18,220 
         

Hydraulics Cylinders and Systems

  11,622   14,729 

Merchandising & Display

  9,523   11,150 

Total Specialty Solutions

  21,145   25,879 
         

Total revenue by product line

 $170,464  $184,774 

 

11

 
 

The following table presents revenue from continuing operations disaggregated by geography based on the Company’s locations (in thousands):

 

  

Three Months Ended

  

Three Months Ended

 

Net sales

 

September 30, 2024

  

September 30, 2023

 

United States

 $100,735  $114,501 

Asia Pacific

  37,696   31,409 

EMEA (1)

  29,269   34,468 

Other Americas

  2,764   4,396 

Total

 $170,464  $184,774 

 

(1)   EMEA consists primarily of Europe, Middle East and S. Africa. 

 

The following table presents revenue from continuing operations disaggregated by timing of recognition (in thousands):

 

  

Three Months Ended

 

Timing of Revenue Recognition

 

September 30, 2024

  

September 30, 2023

 

Products and services transferred at a point in time

 $152,687  $167,225 

Products transferred over time

  17,777   17,549 

Net sales

 $170,464  $184,774 

 

12

Contract Balances

 

Contract assets represent sales recognized in excess of billings related to work completed but not yet shipped for which revenue is recognized over time. Contract assets are recorded as prepaid expenses and other current assets. Contract liabilities are customer deposits for which revenue has not been recognized. Current contract liabilities are recorded as accrued liabilities.

 

The timing of revenue recognition, invoicing and cash collections results in billed receivables, contract assets and contract liabilities on the consolidated balance sheets. When consideration is received from a customer prior to transferring goods or services to the customer under the terms of a contract, a contract liability is recorded. Contract liabilities are recognized as revenue after control of the goods and services are transferred to the customer and all revenue recognition criteria have been met.

 

The following table provides information about contract assets and liability balances (in thousands):

 

  

June 30, 2024

  

Additions

  

Deductions

  

September 30, 2024

 

Three months ended September 30, 2024

                

Contract assets:

                

Prepaid expenses and other current assets

 $45,393  $16,865  $12,171  $50,087 

Contract liabilities:

                

Customer deposits

  1,766   1,803   2,069   1,500 

 

  

June 30, 2023

  

Additions

  

Deductions

  

September 30, 2023

 

Three months ended September 30, 2023

                

Contract assets:

                

Prepaid expenses and other current assets

 $31,138  $16,396  $15,072  $32,462 

 

We recognized the following revenue which was included in the contract liability beginning balances (in thousands):

 

  

Three months ended

 

Revenue recognized in the period from:

 

September 30, 2024

 

Amounts included in the contract liability balance at the beginning of the period

 $1,766 

 

13

 
 

4)      Fair Value Measurements

 

The financial instruments shown below are presented at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Where available, fair value is based on observable market prices or parameters or derived from such prices or parameters. Where observable prices or inputs are not available, valuation models may be applied.

 

Assets and liabilities recorded at fair value in the consolidated balance sheet are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Hierarchical levels directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities and the methodologies used in valuation are as follows:

 

Level 1 – Quoted prices (unadjusted) in active markets for identical assets and liabilities. The Company’s deferred compensation plan assets consist of shares in various mutual funds (investments are participant-directed) which invest in a broad portfolio of debt and equity securities. These assets are valued based on publicly quoted market prices for the funds’ shares as of the balance sheet dates.

 

Level 2 – Inputs, other than quoted prices in an active market, that are observable either directly or indirectly through correlation with market data. For foreign exchange forward contracts and interest rate swaps, the Company values the instruments based on the market price of instruments with similar terms, which are based on spot and forward rates as of the balance sheet dates. The Company has considered the creditworthiness of counterparties in valuing all assets and liabilities.

 

Level 3 – Unobservable inputs based upon the Company’s best estimate of what market participants would use in pricing the asset or liability.

 

There were no transfers of assets or liabilities between any levels of the fair value measurement hierarchy at September 30, 2024 or  June 30, 2024. The Company’s policy is to recognize transfers between levels as of the date they occur.

 

Cash and cash equivalents, accounts receivable, accounts payable, and debt are carried at cost, which approximates fair value.

 

The fair values of financial instruments were as follows (in thousands):

 

  

September 30, 2024

 
  

Total

  

Level 1

  

Level 2

  

Level 3

 

Assets

                

Marketable securities - deferred compensation plan

 $4,838  $4,838  $-  $- 

Interest rate swaps

  2,537   -   2,537   - 

Debt securities

  2,784   -   -   2,784 

Equity securities

  2,088   -   -   2,088 
                 

Liabilities

                

Foreign exchange contracts

 $162  $-  $162  $- 

Contingent consideration (a)

  660   -   -   660 

 

  

June 30, 2024

 
  

Total

  

Level 1

  

Level 2

  

Level 3

 

Assets

                

Marketable securities - deferred compensation plan

 $4,917  $4,917  $-  $- 

Interest rate swaps

  4,673   -   4,673   - 

Debt securities

  2,679   -   -   2,679 

Equity securities

  2,009   -   -   2,009 
                 

Liabilities

                

Contingent consideration(a)

 $660  $-  $-  $660 

 

14

 

(a) The fair value of our contingent consideration arrangement is determined based on our evaluation as to the probability and amount of any deferred compensation that has been earned to date.

 

The Company is obligated to pay contingent consideration to the sellers of SEPL in the event that certain financial targets are achieved during the two years following acquisition, which occurred in the fourth quarter of fiscal year 2024.  As of September 30, 2024, the maximum liability under this arrangement is $0.7 million. 

 

The Company has determined the fair value of the liabilities for the contingent consideration based on a probability-weighted discounted cash flow analysis. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement within the fair value hierarchy. The fair value of the contingent consideration liability associated with future payments was based on several factors, the most significant of which are the financial performance of the acquired businesses and the risk-adjusted discount rate for the fair value measurement.

 

Additionally, the Company has financial assets based upon Level 3 inputs, which represent investments in a privately held company.

 

The Company invested $2.1 million for equity securities of a company whose securities are not publicly traded and where fair value is not readily available. This was recorded as an investment within other non-current assets in the consolidated balance sheets to reflect the initial fair value of the stock acquired. These investments are recorded using either the equity method of accounting or the cost minus impairment adjusted for observable price changes, depending on ownership percentage and other factors that suggest significant influence. The Company concluded it does not have a significant ownership percentage or influence. The Company monitors this investment to evaluate whether any increase or decline in the value has occurred, based on the implied value of recent company financings, public market prices of comparable companies and general market conditions.

 

In the third quarter of fiscal year 2023, the Company also purchased $2.8 million of debt securities from the same privately held company. The available for sale asset was recorded as a current asset in the prepaid expenses and other current assets line of the consolidated balance sheet to reflect the initial fair value of the instrument acquired. This asset was originally due to mature one year from the date of issuance. In the first quarter of fiscal year 2025, the maturity was extended to the end of the third quarter of fiscal year 2025. Available-for-sale debt securities are recorded at fair market value and unrealized gains and losses are included in accumulated other comprehensive income (loss) in equity, net of related tax effects. Realized gains and losses are reported in other non-operating (income) expense, net.

 

There have been no changes in the fair value of the estimates for the Level 3 assets in fiscal year 2025 other than the impact of foreign exchange, which represents the increase in the fair values from the prior year. 

 

The Company updates its assumptions each reporting period based on new developments and records such amounts at fair value based on the revised assumptions until the agreements expire.

 

 

5)     Inventories

 

Inventories from continuing operations are comprised of the following (in thousands):

 

   

September 30, 2024

   

June 30, 2024

 

Raw materials

  $ 47,830     $ 44,536  

Work in process

    13,805       16,202  

Finished goods

    28,486       26,368  

Total

  $ 90,121     $ 87,106  

 

 

Distribution costs associated with the sale of inventory, which are recorded as a component of selling, general and administrative expenses in the accompanying unaudited condensed consolidated statements of operations were $2.4 million and $3.1 million for the three months ended  September 30, 2024 and 2023, respectively. 

 

15

 
 

6)     Goodwill

 

Changes to goodwill by reportable segment during the period were as follows (in thousands):

 

   

June 30, 2024

   

Acquisitions

   

Translation Adjustment

   

September 30, 2024

 

Electronics

  $ 149,910     $ 1,024     $ 9,018     $ 159,952  

Engraving

    76,605       -       345       76,950  

Scientific

    15,454       -       -       15,454  

Engineering Technologies

    36,255       -       510       36,765  

Specialty Solutions

    3,059       -       -       3,059  

Total

  $ 281,283     $ 1,024     $ 9,873     $ 292,180  

 

 

 

7)     Warranty Reserves

 

The expected cost associated with warranty obligations on our products is recorded as a component of cost of sales when the revenue is recognized. The Company’s estimate of warranty cost is based on contract terms and historical warranty loss experience that is periodically adjusted for recent actual experience. Since warranty estimates are forecasts based on the best available information, claims costs may differ from amounts provided. Adjustments to initial obligations for warranties are made as changes in the obligations become reasonably estimable.
 
The change in warranty reserves from continuing operations, which are recorded as a component of accrued liabilities were as follows (in thousands):
 
   

September 30, 2024

   

June 30, 2024

 

Balance at beginning of year

  $ 2,209     $ 2,094  

Acquisitions and other charges

    28       92  

Warranty expense

    293       2,230  

Warranty claims

    (204 )     (2,207 )

Balance at end of period

  $ 2,326     $ 2,209  

 

 

 

8)     Debt

 

Long-term debt is comprised of the following (in thousands):

 

  

September 30, 2024

  

June 30, 2024

 

Bank credit agreements

 $150,000  $150,000 

Total funded debt

  150,000   150,000 

Issuance cost

  (1,015)  (1,124)

Total long-term debt

 $148,985  $148,876 

 

 

16

Bank Credit Agreements

 

During the third quarter of fiscal year 2023, the Company entered into a Third Amended & Restated Credit Agreement which renewed the existing Credit Agreement for an additional five-year period (“Credit Facility”, or “Facility”). The Facility has a borrowing limit of $500 million, which can be increased by an amount of up to $250 million, in accordance with specified conditions contained in the agreement. The Facility also includes a $10 million sublimit for swing line loans and a $35 million sublimit for letters of credit.

 

At September 30, 2024, the Company had standby letters of credit outstanding, primarily for insurance purposes, of $3.1 million and had the ability to borrow $337.3 million under the facility. Funds borrowed under the Facility  may be used for the repayment of debt, working capital, capital expenditures, acquisitions (so long as certain conditions, including a specified funded debt to EBITDA leverage ratio, are maintained), and other general corporate purposes.  The Facility contains customary representations, warranties and restrictive covenants, as well as specific financial covenants which the Company was compliant with as of  September 30, 2024.  At September 30, 2024, the carrying value of the current borrowings approximates fair value.

 

 

9)       Accrued Liabilities

 

Accrued liabilities consist of the following (in thousands):

 

  

September 30, 2024

  

June 30, 2024

 

Payroll and employee benefits

 $19,438  $26,657 

Operating lease current liability

  8,481   8,289 

Warranty reserves

  2,326   2,209 

Restructuring costs

  1,304   1,447 

Workers' compensation

  1,373   1,135 

Contingent consideration

  330   330 

Fair value of derivatives

  162   - 

Other

  19,471   16,631 

Total

 $52,885  $56,698 

 

 

10)      Derivative Financial Instruments

 

The Company is exposed to market risks from changes in interest rates, commodity prices and changes in foreign currency rates. The Company selectively uses derivative financial instruments in order to manage certain of these risks. Information about the Company’s derivative financial instruments is as follows:

 

Interest Rate Swaps

 

From time to time as dictated by market opportunities, the Company enters into interest rate swap agreements designed to manage exposure to interest rates on the Company’s variable rate indebtedness. The Company recognizes all derivatives on its consolidated balance sheets at fair value. The Company has designated its interest rate swap agreements, including those that may be forward-dated, as cash flow hedges, and changes in the fair value of the swaps are recognized in accumulated other comprehensive income until the hedged items are recognized in earnings. Hedge ineffectiveness, if any, associated with the swaps is reported in earnings within interest expense.

 

The Company’s effective swap agreements convert the base borrowing rate on $150 million of debt due under our Facility from a variable rate equal to 1 month Secured Overnight Financing Rate (SOFR) to a weighted average fixed rate of 0.85% at September 30, 2024. The fair value of the swaps, recognized in accumulated other comprehensive income, is as follows (in thousands, except percentages):

 

Effective Date

 

Notional Amount

 

Fixed Interest Rate

 

Maturity

 

September 30, 2024

 

June 30, 2024

 

February 23, 2023

  100,000  0.86%

March 23, 2025

 $1,644 $3,045 

May 25, 2023

  25,000  0.81% 

April 24, 2025

  480  863 

February 24, 2023

  25,000  0.86% 

March 24, 2025

  413  765 
           $2,537 $4,673 

 

17

The Company reported no losses for the three months ended September 30, 2024, as a result of hedge ineffectiveness. Future changes in these swap arrangements, including termination of the agreements, may result in a reclassification of any gain or loss reported in accumulated other comprehensive income (loss) into earnings as an adjustment to interest expense. Accumulated other comprehensive income (loss) related to these instruments is being amortized into interest expense concurrent with the hedged exposure.

 

Foreign Exchange Contracts

 

Forward foreign currency exchange contracts are used to limit the impact of currency fluctuations on certain anticipated foreign cash flows, such as collections from customers and loan payments between subsidiaries. The Company enters into such contracts for hedging purposes only.  At September 30, 2024 and June 30, 2024, the Company had outstanding forward contracts related to hedges of intercompany loans with net unrealized losses of $0.2 million and net unrealized gains of less than $0.1 million, respectively, which approximate the unrealized gains and losses on the related loans. The contracts have maturity dates through fiscal year 2025, which correspond to the related intercompany loans.

 

The notional amounts of the Company’s forward contracts, by currency, are as follows (in thousands):

 

Currency

 

September 30, 2024

  

June 30, 2024

 

USD

 3,000  4,159 

CAD

 6,079  6,079 

 

The table below presents the fair value of derivative financial instruments as well as their classification on the balance sheet (in thousands):

 

 

Asset Derivatives

 
 

September 30, 2024

 

June 30, 2024

 

Derivative designated

Balance Sheet

    

Balance Sheet

    

as hedging instruments

Line Item

  Fair Value 

Line Item

  Fair Value 

Interest rate swaps

Prepaid expenses and other current assets

 $2,537 

Prepaid expenses and other current assets

 $4,673 

 

 

Liability Derivatives

 
 

September 30, 2024

 

June 30, 2024

 

Derivative designated

Balance Sheet

    

Balance Sheet

    

as hedging instruments

Line Item

  Fair Value 

Line Item

  Fair Value 

Foreign exchange contracts

Accrued liabilities

 $- 

Accrued liabilities

 $- 

 

18

 

The table below presents the amount of gain (loss) recognized in comprehensive income on our derivative financial instruments (effective portion) designated as hedging instruments and their classification within comprehensive income for the periods ended (in thousands):

 

  

Three Months Ended

 
  

September 30,

 
  

2024

  

2023

 

Interest rate swaps

 $(384) $628 

Foreign exchange contracts

  -   315 
  $(384) $943 

 

The table below presents the amount reclassified from accumulated other comprehensive income (loss) to net income for the periods ended (in thousands):

 

Details about Accumulated

        

Affected line item

Other Comprehensive

 

Three Months Ended

 

in the Unaudited

Income (Loss) Components

 

September 30,

 

Condensed Statements

  

2024

  

2023

 

of Operations

Interest rate swaps

 $(1,697) $(1,720)

Interest expense

Foreign exchange contracts

  -   (215)

Other non-operating (income) expense, net

  $(1,697) $(1,935) 

 

 

11)     Retirement Benefits

 

The Company has defined benefit pension plans covering certain current and former employees both inside and outside of the U.S. The Company’s pension plan for U.S. employees is frozen for substantially all participants and has been replaced with a defined contribution benefit plan. 

 

Net periodic benefit cost for the Company’s U.S. and foreign pension benefit plans for the periods ended consisted of the following components (in thousands):

 

  

U.S. Plans

  

Non-U.S. Plans

 
  

Three Months Ended

  

Three Months Ended

 
  

September 30,

  

September 30,

 
  

2024

  

2023

  

2024

  

2023

 

Service cost

 $-  $-  $63  $41 

Interest cost

  2,386   2,473   306   297 

Expected return on plan assets

  (2,641)  (2,779)  (347)  (353)

Recognized net actuarial loss

  1,055   951   -   (152)

Amortization of prior service cost

  -   -   (1)  (1)

Net periodic (benefit) cost

 $800  $645  $21  $(168)

 

19

The following table sets forth the amounts recognized for the Company's defined benefit pension plans (in thousands):

 

Amounts recognized in the consolidated balance sheets consist of:

 

September 30, 2024

  

June 30, 2024

 

Prepaid benefit cost

 $2,816  $2,570 

Current liabilities

  (262)  (791)

Non-current liabilities

  (40,088)  (42,667)

Net amount recognized

 $(37,534) $(40,888)

 

The contributions made to defined benefit plans are presented below along with remaining contributions to be made for fiscal year 2025 (in thousands):

 

  

Fiscal Year 2025

  

Remaining

 
  

Three Months Ended

  

Contributions

 

Contributions to defined benefit plans

 

September 30, 2024

  

FY 2025

 

United States, funded plan

 $3,352  $2,485 

United States, unfunded plan

  27   144 

Germany, unfunded plan

  -   263 
  $3,379  $2,892 

 

 

12)     Income Taxes

 

The Company's effective tax rate from continuing operations for the first quarter of fiscal year 2025 was 21.4% compared with 23.8% for the prior year quarter. 


The tax rate was impacted in the current period by the following items: (i) a discrete tax benefit related to equity compensation, (ii) variations in the geographical mix of earnings; (iii) foreign withholding taxes and (iv) tax credits linked to federal research and development activities. The tax rate was impacted in the prior period by the following items: (i) a discrete tax benefit related to equity compensation, (ii) the jurisdictional mix of earnings, (iii) foreign withholding taxes, and (iv) federal research and development tax credits.

 
20

 

 

13)     Earnings Per Share

 

The Company uses shares acquired through treasury stock repurchases for the issuance of shares of common stock for the settlement of awards under its stock-based compensation plans, with the net effect of these transactions accounting for the change in common stock outstanding.

 

The following table sets forth a reconciliation of the number of shares (in thousands) used in the computation of basic and diluted earnings per share:

 

  

Three Months Ended

 
  

September 30,

 
  

2024

  

2023

 

Basic - Average shares outstanding

  11,787   11,742 

Dilutive effect of unvested, restricted stock awards

  117   191 

Diluted - Average shares outstanding

  11,904   11,933 

 

Earnings available to common stockholders are the same for computing both basic and diluted earnings per share. There were no outstanding instruments that had an anti-dilutive effect at September 30, 2024 or 2023.

 

Performance stock units of 81,704 and 89,434 for the three months ended  September 30, 2024 and 2023, respectively, are excluded from the diluted earnings per share calculation as the performance criteria have not been met.

 

 

14)     Accumulated Other Comprehensive Income (Loss)

 

The components of the Company’s accumulated other comprehensive income (loss) are as follows (in thousands):

 

   

September 30, 2024

   

June 30, 2024

 

Foreign currency translation adjustment

  $ (68,918 )   $ (91,928 )

Unrealized pension losses, net of tax

    (94,935 )     (95,516 )

Unrealized gains (losses) on derivative instruments, net of tax

    2,914       4,488  

Total

  $ (160,939 )   $ (182,956 )

   

 

15)     Contingencies

 

From time to time, the Company is subject to various claims and legal proceedings, including claims related to environmental remediation, either asserted or unasserted, that arise in the ordinary course of business. While the outcome of these proceedings and claims cannot be predicted with certainty, the Company’s management does not believe that the outcome of any of the currently existing legal matters will have a material impact on the Company’s consolidated financial position, results of operations or cash flow. The Company accrues for losses related to a claim or litigation when the Company’s management considers a potential loss probable and can reasonably estimate such potential loss.

 

21

 
 

16)     Industry Segment Information

 

The Company has five reportable segments organized around the types of products sold:

 

 

Electronics – manufactures and sells electronic components for applications throughout the end user market spectrum;

 

Engraving – provides mold texturizing, slush molding tools, project management and design services, roll engraving, hygiene product tooling, low observation vents for stealth aircraft, and process machinery for a number of industries; 

 

Scientific – sells specialty temperature-controlled equipment for the medical, scientific, pharmaceutical, biotech and industrial markets; 

 

Engineering Technologies – provides net and near net formed single-source customized solutions in the manufacture